Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Monday. Here are some big stocks recording gains in today’s session.
Radian Group Q4 EPS $1.05 Beats $0.75 Estimate, Sales $232.83M Miss $243.02M Estimate
Radian Group (NYSE:RDN) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $0.75 by 40 percent. This is a 1.87 percent decrease over earnings of $1.07 per share from the same
5 Value Stocks To Watch In The Financial Services Sector
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices…
Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023
Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…
B of A Securities Upgrades Radian Group to Buy, Announces $24 Price Target
B of A Securities analyst Mihir Bhatia upgrades Radian Group (NYSE:RDN) from Neutral to Buy and announces $24 price target.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 167 companies set new 52-week lows.
BTIG Downgrades Radian Group to Neutral
BTIG analyst Eric Hagen downgrades Radian Group (NYSE:RDN) from Buy to Neutral.
What 4 Analyst Ratings Have To Say About Radian Group
Within the last quarter, Radian Group (NYSE:RDN) has observed the following analyst ratings:
Compass Point Downgrades Radian Group to Neutral, Lowers Price Target to $22.5
Compass Point analyst Giuliano Bologna downgrades Radian Group (NYSE:RDN) from Buy to Neutral and lowers the price target from $28 to $22.5.
Keefe, Bruyette & Woods Upgrades Radian Group to Outperform, Lowers Price Target to $25
Keefe, Bruyette & Woods analyst Bose George upgrades Radian Group (NYSE:RDN) from Market Perform to Outperform and lowers the price target from $27 to $25.